Related Experiment Video
Updated: May 6, 2026

08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
13.0K
The evolution of polyclonal competition in aging hematopoiesis
Nathaniel V Mon Père1, Francesco Terenzi1, Benjamin Werner1
1Barts Cancer Institute, Queen Mary University of London London United Kingdom.
Cancer Discovery
|May 5, 2026
Summary
Clonal hematopoiesis (CH), the expansion of genetic variants in blood, is explained by a model of polyclonal competition. This research identifies early indicators of hematologic malignancies, enabling potential interventions.
Area of Science:
- Somatic evolution and hematopoiesis.
- Genetics and molecular biology.
- Computational biology and evolutionary modeling.
Background:
- Clonal hematopoiesis (CH) involves genetic variant expansion in blood, a key aspect of somatic evolution.
- While CH often precedes malignant transformation, its underlying dynamics remain incompletely understood.
- Understanding CH is crucial for identifying early signs of hematologic malignancies.
Purpose of the Study:
- To explain the dynamics of clonal hematopoiesis (CH) throughout human life using a competitive model.
- To quantify the fitness distribution and occurrence rate of clonal expansions.
- To investigate the evolutionary patterns of specific genetic variants associated with CH.
Main Methods:
- Development and application of a polyclonal competition model to explain CH dynamics.
- Quantification of clonal expansion fitness and occurrence rates using variant trajectories and HSC genetic heterogeneity.
- Analysis of variant enrichment patterns (single-hit vs. multi-hit) for specific genes (DNMT3A, TET2, ASXL1, JAK2, SF3B1, SRSF2).
Main Results:
- The model of polyclonal competition accurately explains observed CH dynamics across the human lifespan.
- Approximately three fit clones emerge annually in the HSC pool, with rarely more than five exceeding 1.5% frequency.
- Fittest clones predominantly emerge later in life, consistent with multistep evolutionary processes.
- DNMT3A variants showed enrichment for single-hit clones, while TET2, ASXL1, JAK2, SF3B1, and SRSF2 variants were enriched for multi-hit evolution.
Conclusions:
- CH dynamics can be effectively modeled by polyclonal competition, offering insights into somatic evolution in blood.
- Specific genetic variants exhibit distinct evolutionary patterns, suggesting different pathways to clonal expansion.
- Precursors to hematologic malignancies are potentially identifiable before transformation, paving the way for early intervention strategies.
Related Concept Videos
Hematopoiesis
8.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.1K
Regulation of Hematopoietic Stem Cells
3.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
Overview of Hematopoiesis
9.9K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
9.9K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Role of Hematopoietic Growth Factors
3.9K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Lineage Commitment
3.4K
Commitment is the process whereby stem cells:
3.4K

